Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 3/2018

19.08.2017 | Original Paper

Cardiac death in patients with left ventricular aneurysm, remodeling and myocardial viability by gated 99mTc-MIBI SPECT and gated 18F-FDG PET

verfasst von: Weixue Wang, Xiang Li, Congna Tian, Shihua Zhao, Marcus Hacker, Xiaoli Zhang

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

(1) To evaluate the prognostic value of LV remodeling parameters in patients with LV aneurysm by gated SPECT (GSPECT), gated PET (GPET) and CMR; (2) to evaluate the impact of myocardial viability and LV remodeling on the long-term cardiac survival in patients with LV aneurysm. One hundred and twenty-six consecutive patients underwent GPET, GSPECT and CMR within two weeks, with a mean follow-up of 3.9 ± 1.5 years. End-diastolic volume (EDV, mL) and end-systolic volume (ESV, mL) measured by GPET, GSPECT and CMR and corrected for BSA; EDVI and ESVI were calculated. Patients were divided into three groups by aneurysmal viability [mismatch score (MMS) of aneurysm ≥2.0] and LV remodeling (ESVI by GPET > 60 mL/m2). Group 1 (Viability −, LV remodeling −); Group 2 (Viability −, LV remodeling +) and Group 3 (Viability +, LV remodeling −/+). ESVI by GPET, MMS of aneurysm and summed rest score of aneurysm by multivariate regression analysis; as well as ESVI by GPET (HR 1.024, 95% CI 1.011–1.037, p = .0004), MMS of aneurysm (HR 1.284, 95% CI 1.051–1.577, p = .015) by interaction analysis were approved being independent predictors for cardiac death (p < .05). The long-term cardiac survival was significantly improved by revascularization in comparison with medical therapy in Group3 (p < .01), but did not significantly differ between Groups 1 and 2. ESVI by GPET showed a significant positive predictive value for cardiac death. Patients with viable myocardial aneurysm were most likely at increased risk for cardiac death and coronary revascularization was significantly associated with improved long-term cardiac survival. In contrast, the long-term cardiac survival of patients without LV remodeling and without aneurysmal viability was promising and, thus, could be treated by medical therapy.
Literatur
1.
Zurück zum Zitat Anzai T (2013) Post-infarction inflammation and left ventricular remodeling. Circ J 77:580–587CrossRefPubMed Anzai T (2013) Post-infarction inflammation and left ventricular remodeling. Circ J 77:580–587CrossRefPubMed
2.
Zurück zum Zitat Mittal S, Aktas MK, Moss AJ, McNitt S, Kutyifa V, Steinberg JS, Zareba W (2014) The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT. J Cardiovasc Electrophysiol 25:1082–1087CrossRefPubMed Mittal S, Aktas MK, Moss AJ, McNitt S, Kutyifa V, Steinberg JS, Zareba W (2014) The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT. J Cardiovasc Electrophysiol 25:1082–1087CrossRefPubMed
3.
Zurück zum Zitat Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G, Opie L (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383:1933–1943CrossRefPubMedPubMedCentral Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G, Opie L (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383:1933–1943CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB (2016) Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133:e38–e360CrossRefPubMed Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB (2016) Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133:e38–e360CrossRefPubMed
5.
6.
Zurück zum Zitat Yoshida M, Hirota M, Hoshino J, Kondo T, Isomura T (2015) Prediction of long-term survival in patients with end-stage heart failure secondary to ischemic heart disease: surgical correction and volumetric analysis. Ann Thorac Cardiovasc Surg 21:551–556CrossRefPubMedPubMedCentral Yoshida M, Hirota M, Hoshino J, Kondo T, Isomura T (2015) Prediction of long-term survival in patients with end-stage heart failure secondary to ischemic heart disease: surgical correction and volumetric analysis. Ann Thorac Cardiovasc Surg 21:551–556CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Bonow RO, Castelvecchio S, Panza JA, Berman DS, Velazquez EJ, Michler RE, She L, Holly TA, Desvigne-Nickens P, Kosevic D, Rajda M, Chrzanowski L, Deja M, Lee KL, White H, Oh JK, Doenst T, Hill JA, Rouleau JL, Menicanti L, Stich Trial Investigators (2015) Severity of remodeling, myocardial viability, and survival in ischemic LV dysfunction after surgical revascularization. JACC Cardiovasc Imaging 8:1121–1129CrossRefPubMedPubMedCentral Bonow RO, Castelvecchio S, Panza JA, Berman DS, Velazquez EJ, Michler RE, She L, Holly TA, Desvigne-Nickens P, Kosevic D, Rajda M, Chrzanowski L, Deja M, Lee KL, White H, Oh JK, Doenst T, Hill JA, Rouleau JL, Menicanti L, Stich Trial Investigators (2015) Severity of remodeling, myocardial viability, and survival in ischemic LV dysfunction after surgical revascularization. JACC Cardiovasc Imaging 8:1121–1129CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Kwon DH, Hachamovitch R, Popovic ZB, Starling RC, Desai MY, Flamm SD, Lytle BW, Marwick TH (2012) Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability. Circulation 126:S3–S8CrossRefPubMed Kwon DH, Hachamovitch R, Popovic ZB, Starling RC, Desai MY, Flamm SD, Lytle BW, Marwick TH (2012) Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability. Circulation 126:S3–S8CrossRefPubMed
9.
Zurück zum Zitat Anagnostopoulos CD, Cokkinos DV (2011) Prediction of left ventricular remodelling by radionuclide imaging. Eur J Nucl Med Mol Imaging 38:1120–1123CrossRefPubMed Anagnostopoulos CD, Cokkinos DV (2011) Prediction of left ventricular remodelling by radionuclide imaging. Eur J Nucl Med Mol Imaging 38:1120–1123CrossRefPubMed
10.
Zurück zum Zitat Wei H, Tian C, Schindler TH, Qiu M, Lu M, Shen R, Tian Y, Zhao SH, Zhang X (2014) The impacts of severe perfusion defects, akinetic/dyskinetic segments, and viable myocardium on the accuracy of volumes and LVEF measured by gated 99mTc-MIBI SPECT and gated 18F-FDG PET in patients with left ventricular aneurysm: cardiac magnetic resonance imaging as the reference. J Nucl Cardiol 21:1230–1244CrossRefPubMed Wei H, Tian C, Schindler TH, Qiu M, Lu M, Shen R, Tian Y, Zhao SH, Zhang X (2014) The impacts of severe perfusion defects, akinetic/dyskinetic segments, and viable myocardium on the accuracy of volumes and LVEF measured by gated 99mTc-MIBI SPECT and gated 18F-FDG PET in patients with left ventricular aneurysm: cardiac magnetic resonance imaging as the reference. J Nucl Cardiol 21:1230–1244CrossRefPubMed
11.
Zurück zum Zitat Lim SP, Mc Ardle BA, Beanlands RS, Hessian RC (2014) Myocardial viability: it is still alive. Semin Nucl Med 44:358–374CrossRefPubMed Lim SP, Mc Ardle BA, Beanlands RS, Hessian RC (2014) Myocardial viability: it is still alive. Semin Nucl Med 44:358–374CrossRefPubMed
12.
Zurück zum Zitat Zhang X, Liu XJ, Hu S, Schindler TH, Tian Y, He ZX, Gao R, Wu Q, Wei H, Sayre JW, Schelbert HR (2008) Long-term survival of patients with viable and nonviable aneurysms assessed by 99mTc-MIBI SPECT and 18F-FDG PET: a comparative study of medical and surgical treatment. J Nucl Med 49:1288–1298CrossRefPubMed Zhang X, Liu XJ, Hu S, Schindler TH, Tian Y, He ZX, Gao R, Wu Q, Wei H, Sayre JW, Schelbert HR (2008) Long-term survival of patients with viable and nonviable aneurysms assessed by 99mTc-MIBI SPECT and 18F-FDG PET: a comparative study of medical and surgical treatment. J Nucl Med 49:1288–1298CrossRefPubMed
13.
Zurück zum Zitat Zhang X, Liu XJ, Wu Q, Shi R, Gao R, Liu Y, Hu S, Tian Y, Guo S, Fang W (2001) Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial 99mTc-MIBI SPECT and 18F-FDG PET. J Nucl Med 42:1166–1173PubMed Zhang X, Liu XJ, Wu Q, Shi R, Gao R, Liu Y, Hu S, Tian Y, Guo S, Fang W (2001) Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial 99mTc-MIBI SPECT and 18F-FDG PET. J Nucl Med 42:1166–1173PubMed
14.
Zurück zum Zitat Holly TA, Abbott BG, Al-Mallah M, Calnon DA, Cohen MC, DiFilippo FP, Ficaro EP, Freeman MR, Hendel RC, Jain D, Leonard SM, Nichols KJ, Polk DM, Soman P (2010) Single photon-emission computed tomography. J Nucl Cardiol 17:941–973CrossRefPubMed Holly TA, Abbott BG, Al-Mallah M, Calnon DA, Cohen MC, DiFilippo FP, Ficaro EP, Freeman MR, Hendel RC, Jain D, Leonard SM, Nichols KJ, Polk DM, Soman P (2010) Single photon-emission computed tomography. J Nucl Cardiol 17:941–973CrossRefPubMed
15.
Zurück zum Zitat Hu YM, Wu XL, Hu ZH, Ren AH, Wei XQ, Wang XC, Yu R (1999) Study of formula for calculating body surface areas of the Chinese adults. Acta Physiol Sin 51:45–48 Hu YM, Wu XL, Hu ZH, Ren AH, Wei XQ, Wang XC, Yu R (1999) Study of formula for calculating body surface areas of the Chinese adults. Acta Physiol Sin 51:45–48
16.
Zurück zum Zitat Arsanjani R, Berman DS, Gransar H, Cheng VY, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Callister TQ, Chang HJ, Cademartiri F, Chinnaiyan KM, Chow BJ, DeLago A, Hadamitzky M, Hausleiter J, Kaufmann P, LaBounty TM, Leipsic J, Raff G, Shaw LJ, Villines TC, Cury RC, Feuchtner G, Kim YJ, Min JK (2014) Left ventricular function and volume with coronary CT angiography improves risk stratification and identification of patients at risk for incident mortality: results from 7758 patients in the prospective multinational CONFIRM observational cohort study. Radiology 273:70–77CrossRefPubMed Arsanjani R, Berman DS, Gransar H, Cheng VY, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Callister TQ, Chang HJ, Cademartiri F, Chinnaiyan KM, Chow BJ, DeLago A, Hadamitzky M, Hausleiter J, Kaufmann P, LaBounty TM, Leipsic J, Raff G, Shaw LJ, Villines TC, Cury RC, Feuchtner G, Kim YJ, Min JK (2014) Left ventricular function and volume with coronary CT angiography improves risk stratification and identification of patients at risk for incident mortality: results from 7758 patients in the prospective multinational CONFIRM observational cohort study. Radiology 273:70–77CrossRefPubMed
17.
Zurück zum Zitat Oh JK, Velazquez EJ, Menicanti L, Pohost GM, Bonow RO, Lin G, Hellkamp AS, Ferrazzi P, Wos S, Rao V, Berman D, Bochenek A, Cherniavsky A, Rogowski J, Rouleau JL, Lee KL (2013) Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. Eur Heart J 34:39–47CrossRefPubMed Oh JK, Velazquez EJ, Menicanti L, Pohost GM, Bonow RO, Lin G, Hellkamp AS, Ferrazzi P, Wos S, Rao V, Berman D, Bochenek A, Cherniavsky A, Rogowski J, Rouleau JL, Lee KL (2013) Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. Eur Heart J 34:39–47CrossRefPubMed
18.
Zurück zum Zitat Fernandez SF, Ovchinnikov V, Canty JM Jr, Fallavollita JA (2013) Hibernating myocardium results in partial sympathetic denervation and nerve sprouting. Am J Physiol Heart Circ Physiol 304:H318–H327CrossRefPubMed Fernandez SF, Ovchinnikov V, Canty JM Jr, Fallavollita JA (2013) Hibernating myocardium results in partial sympathetic denervation and nerve sprouting. Am J Physiol Heart Circ Physiol 304:H318–H327CrossRefPubMed
19.
Zurück zum Zitat Schinkel AF, Bax JJ, Delgado V, Poldermans D, Rahimtoola SH (2010) Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction. Am J Med 123:978–986CrossRefPubMed Schinkel AF, Bax JJ, Delgado V, Poldermans D, Rahimtoola SH (2010) Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction. Am J Med 123:978–986CrossRefPubMed
20.
Zurück zum Zitat Buckberg G, Athanasuleas C, Conte J (2012) Surgical ventricular restoration for the treatment of heart failure. Nat Rev Cardiol 9(12):703–716CrossRefPubMed Buckberg G, Athanasuleas C, Conte J (2012) Surgical ventricular restoration for the treatment of heart failure. Nat Rev Cardiol 9(12):703–716CrossRefPubMed
21.
Zurück zum Zitat Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O’Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL (2009) Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 360:1705–1717CrossRefPubMedPubMedCentral Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O’Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL (2009) Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 360:1705–1717CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med 374:1511–1520CrossRefPubMedPubMedCentral Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med 374:1511–1520CrossRefPubMedPubMedCentral
Metadaten
Titel
Cardiac death in patients with left ventricular aneurysm, remodeling and myocardial viability by gated 99mTc-MIBI SPECT and gated 18F-FDG PET
verfasst von
Weixue Wang
Xiang Li
Congna Tian
Shihua Zhao
Marcus Hacker
Xiaoli Zhang
Publikationsdatum
19.08.2017
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 3/2018
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-017-1234-8

Weitere Artikel der Ausgabe 3/2018

The International Journal of Cardiovascular Imaging 3/2018 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.